Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares were up 14.3% during mid-day trading on Tuesday . The company traded as high as C$0.24 and last traded at C$0.24. Approximately 450,853 shares changed hands during mid-day trading, a decline of 2% from the average daily volume of 458,386 shares. The stock had previously closed at C$0.21.
Voyageur Pharmaceuticals Price Performance
The company has a 50-day moving average of C$0.10 and a 200 day moving average of C$0.07. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm has a market cap of C$27.89 million, a P/E ratio of -20.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 3 Best Fintech Stocks for a Portfolio Boost
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
